Tissue engineering is making great strides to repair disease and damage in a wide range of tissues, many of which are high profile and well documented. However, the thymus and secondary lymphoid organs are tissues which have not received significant attention from the research community but are nonetheless important targets for tissue engineering based therapies. These organs are fundamental in developing and maintaining the mammalian immune system and create environments for antigen screening and pathogen removal. This review discusses the function of these organs with reference to tissue development, tissue resident progenitor cells and disease. Subsequently strategies utilised for tissue engineering and regeneration are discussed in conjunction with methods to replicate their function and alternative methods to generate progenitor cells.
Introduction
Tissue engineering is a multidisciplinary research field which aims to reproduce, repair or augment tissue function of whole or partial organs in individuals suffering disease or trauma. The field has roots in clinical medicine and employs the principles of engineering and materials chemistry with cell biology. This involves the selective use of cells, scaffold biomaterials, growth factors and mechanical stimulation in various combinations to recapitulate an organ in vitro or in vivo. It was first mentioned as a distinct area of research in the 1980's, before coming to prominence through Langer and Vacanti's seminal 1993 article Tissue Engineering (Skalak and Fox 1988; Langer and Vacanti 1993) . Since this point thousands of research articles have been published on engineering or repairing practically every organ of the human body, with particular focus on musculoskeletal tissues (2201 publications in 2012), the heart (422) and skin (314). Two groups however, have received comparatively little attention; these are the primary and secondary lymphoid organs (SLO) (less than 10 specific articles in 2012). The primary lymphoid organs are composed of the bone marrow and the thymus, with the thymus being the major site of T cell generation, whilst the SLO comprise lymph nodes and lymphoid follicles in organs such as the spleen, tonsils and adenoids. As a group these organs generate and maintain the mammalian immune system and are fundamental to survival. Despite the comparative lack of effort advances have been made in attempting to regenerate these organs or recapitulate their functions and these will be discussed.
Thymus
The thymus is a primary lymphoid organ responsible for the production and dispersion to the periphery of lymphocytes, generically known as thymocytes or T cells due to their thymic origin (Miller 1961; Zuniga-Pflucker 2004) . T cells develop in the thymus from haematopoietic stem cell (HSC) derived precursor cells which originate in the bone marrow and undergo differentiation, maturation and selection via a series of chemokine mediated cell-cell interactions in specific microenvironments ( Figure 1 ) (Bommhardt et al. 2004 ; Gordon et al. 2004) . Two main classes of T cell exist, CD8 cytotoxic T cells which destroy foreign antigens and CD4 helper T cells which mediate the immune response (Harty et al. 2000; Zhu and Paul 2008) . Other cells produced by the thymus are regulatory T cells (TRegs), which play a major role in immunological self tolerance and negative control of the immune response and natural killer T cells (NKT cells) which are also involved in self tolerance as well as cytokine secretion (Vignali et al. 2008 ; Hegde et al. 2010 ).
Figure 1. Differentiation of HSC derived precursor cells to multiple cell types within the thymus.
Within the bone marrow of long bones, short term repopulating cells (STRC), derived from HSC differentiate to the common lymphoid progenitor (CLP) phenotype prior to entering the blood. CLPs subsequently migrate to the thymus, entering at the cortico-medullary junction, before undergoing a controlled series of molecular changes, the most significant being the expression of the T cell receptor (TCR), whilst passing through, and interacting with, the defined microarchitecture of the thymic cortex. Once the developing T cells express a TCR they migrate to the thymic medulla, at this stage they are known as double positive thymocytes because of their CD4 + CD8 + phenotype. In the medulla developing T cells are subject to positive and negative selection to remove both non-reactive and auto-reactive T cells. It is during this process that T cell lineage commitment is made and cells become either: CD4 + T helper cells, CD8 + cytotoxic T cells, TRegs or NKT cells. The cells are subsequently exported to the periphery, usually to SLO such as the spleen, as naïve cells which become mature and activated upon interaction with a foreign antigen. CD4 + T helper cells undergo a further round of differentiation upon activation to one of the four T helper cell phenotypes or to an induced TReg phenotype. Following activation most cells are lost, however a small subset of each cell type become memory T cells which recognise foreign antigens upon subsequent infection.
Thymus and T Cell Development
T cell development is a complex process involving the up and down regulation of many genes and the rearrangement of cell surface receptors and for this process to function efficiently a normal thymic stromal phenotype of cortex, medulla and subcapsular zone is required (Mohtashami and Zuniga-Pflucker 2006; Sitnicka 2009 ). This phenotype is important because each region has specific functions in thymocyte development and the epithelial cells which make up each region provide a framework upon which developing T cells reside (von Gaudecker et al. 1986; van Ewijk et al. 2000; Milicevic and Milicevic 2004) . One potentially dangerous outcome of incorrect thymocyte development is the generation of autoreactive T cells which fail to recognise self antigens and attack the host's own tissue leading to potentially lethal conditions (Rodewald 2008) . Therefore the thymus also functions to screen and remove potentially dangerous T cells, as well as ensuring T cells which are released to the periphery can recognise and react to foreign antigens (ZunigaPflucker 2004).
Correct differentiation of lymphocytes also has implications for the proper structural development of the thymus because of the need for cellular crosstalk between thymic epithelial cells and progenitor T cells. The absence of T cell progenitors has been shown to lead to abnormal cortical and medullary regions in cultured thymi ( . Disruption of the thymus structure by, for example, chemotherapy, has also been shown to affect T cell generation and patients with DiGeorge syndrome, where a deletion in chromosome 22q11 causes thymic aplasia or hypoplasia, have reduced functional T cells (Hendrickx and Dohring 1989; Greenberg 1993 ). However, recent findings have shown that the thymus is a dynamic environment with some potential inherent regenerative capacity after procedures such as thymectomy during juvenile cardiac surgery van Gent et al. 2011 ). This regenerative capacity is probably controlled by resident progenitor cells and it has been shown that a reduction in the initial progenitor pool reduces subsequent regenerative potential (Jenkinson et al. 2008 ).
Thymus Progenitor Cells
For several years thymic origin and the existence of a thymic epithelial progenitor cell was debated, with suggestions that the thymus had a dual origin and that cortex and medulla were formed by ectodermal and endodermal contributions respectively (Cordier and Haumont 1980). However, data presented in 2002 and 2006 disputed this theory and confirmed, in mice, the presence of a thymic epithelial progenitor cell of endodermal origin which expressed MTS24 and epithelial cell adhesion molecule 1 (EpCAM 1, CD326) and was capable of producing both cortical and medullary regions (Gill et al. 2002; Gordon et al. 2004; Bleul et al. 2006 ; Rossi et al. 2006) . Further studies showed that the protein Placenta-expressed transcript-1 (Plet-1) interacts with the MTS24 marker during thymus organogenesis and can be utilised to study progenitor cell behaviour (Depreter et al. 2008) . The presence of a thymic progenitor cell is an important finding as it suggests the possibility of stimulating endogenous thymic regeneration clinically and also because further study may elucidate the mechanisms of differentiation which can then be utilised in stem cell differentiation experiments.
Thymus Disease and Atrophy
One aspect of thymus biology where it varies with other organs is age related atrophy; which is the progressive replacement of stromal tissue with fatty deposits. This process leads to a reduction in overall thymus stromal volume and subsequently a reduction in its capacity to generate naïve T cells. In healthy individuals atrophy begins at puberty and persists throughout adulthood, however recent evidence suggests that chronic infections or autoimmune disorders can trigger an upregulation in tumour necrosis factor (TNF) levels, which may in turn accelerate the process meaning individuals can become immunocompromised due to a reduction in thymopoiesis (Liepinsh et al. 2009 ).
Aside from pre-programmed atrophy and infection, there are several other instances whereby thymus function is impaired, either congenitally or by acquirement. The most striking example of a congenital condition is DiGeorge syndrome which is a multifaceted disorder resulting from a deletion in chromosome 22q11 causing thymic hypoplasia, leading to significantly reduced T cell generation and an increased susceptibility to infections (Greenberg 1993) . The symptoms of DiGeorge syndrome vary greatly and as well as thymic hypoplasia can include cardiac and facial abnormalities, cleft palate and hypoparathyroidism. Another congenital condition that leads to thymic dysplasia is severe combined immunodeficiency syndrome (SCID), which can be caused by several different genetic factors and is characterised by a nonfunctional immune response leading to increased susceptibility to infections (Bosma et al. 1983 ). This lack of response is due to the incorrect development of lymphocyte precursor cells in the bone marrow, leading to a significant reduction in the number of precursor cells migrating to the thymus. This subsequently has negative impacts on thymus development and homeostasis and leads to thymus atrophy due to the importance of cellular crosstalk between thymic epithelial cells and developing T lymphocytes ( HIV infection is the most studied cause of acquired thymic atrophy and is due to the destruction of T cells within the thymus, leading to the loss of thymic cortex (Grody et al. 1985) . In addition, various other chronic bacterial, fungal and parasitic infections can lead to thymus atrophy, again due to loss of T cells with the possible involvement of the TNF pathway (Savino 2006 ; Gruver and Sempowski 2008; Liepinsh et al. 2009 ). Many of these chronic infections cause severe depletion of circulating T cells, as well as thymus atrophy, meaning that individuals become immunocompromised because they are less capable of replacing peripheral T cells lost due to infection. In addition to infection induced atrophy is the phenomena of stress induced atrophy (Gruver and Sempowski 2008) . In these instances environmental stresses such as malnutrition and emotional stress can lead to involution of the thymus with an associated reduction in lymphopoiesis, leading to individuals becoming immunocompromised during episodes of acute stress. The precise mechanism of this process is not fully understood but it is known to be reversible, highlighting the inherent regenerative capacity present within the thymus. For this reason studies to investigate the molecular signals behind this 'rebound' effect, and potentially harness it, are ongoing.
The above examples pertain to diseases where various factors lead to thymus atrophy with subsequent reductions in function; however there are also diseases where thymic hyperplasia or hypertrophy is associated with a disease. For example one of the symptoms of the neuromuscular autoimmune disorder Myasthenia Gravis (MG) is hyperplasia in the thymus medulla with alterations in cell patterning and differences in T cell rich areas compared to healthy controls (Bofill et al. 1985; Hofmann et al. 1987) . The specific pathology of MG is a current area of research but evidence suggests that incorrect recruitment and development of lymphocytes to and within the thymus is a causative reason for the disease with thymectomy often used as a treatment for MG patients (Balandina et Studies which have utilised synthetic scaffolds to engineer a thymus have shown some promise in generating in vitro thymus tissue. In 2000 Poznansky et al. generated a thymic organoid in vitro using cultured thymic stromal cells on tantalum coated carbon scaffolds prior to the addition of lymphocyte precursor cells (Figure 3 ) (Poznansky et al. 2000) . Following a two week culture period the emerging T cells were assessed phenotypically and were found to have mature CD4
+ and CD8 + phenotypes, functional assessment also found evidence of a response to external challenge. From this study the importance of both scaffold porosity and pore size for cell attachment and development were shown and also the potential for the in vitro generation of T cells. Figure 4 shows a further example of an engineered thymic organoid, in this model embryonic mouse thymic epithelial cells, sorted for the expression of EpCAM-1, were cultured on electrospun poly-L-lactic acid scaffolds in a rotating bioreactor, though these constructs were not tested for functionality.
Mouse chamber model studies with foetal mouse thymus tissue, encapsulated within Matrigel and a silicone chamber prior to implantation into the inguinal fat pad of athymic mice, showed the potential to generate functional T cells within a cell-scaffold construct (Seach et al. 2010 ). These murine tissue engineered constructs were vascularised and viable 11 weeks after implantation; however human paediatric thymus tissue treated using the same experimental regimen showed more limited success. Despite the success of this model in generating functional T cells, its limited success with sustaining human thymus tissue makes this model more suitable for the study of lymphopoiesis.
Alternative strategies to repair the thymus are based on endogenous tissue regeneration. Studies of thymus cortical epithelial cells, sensitised to, and treated with diphtheria toxin showed cell death followed by endogenous regeneration after cessation of treatment with an associated restoration of T cell generation (Rode and Boehm 2012). This study highlights the latent regenerative capacity thymus epithelium possesses, however the molecular signals which guide this process must be elucidated before this functionality can be utilised in a clinical environment. One molecule involved in thymus regeneration is interleukin 22 (IL-22) which has been shown to be upregulated following thymus injury (Dudakov et al. 2012) . This molecule was shown to enhance thymic regeneration when administered following irradiation, indicating its potential utility in Figure 3 . Development of an in vitro thymic organoid. Protocol as described by Poznansky et al. (2000) . Isolated thymi from adult mice were dissociated to give a tissue fragments (A), these fragments were subsequently cultured on the surface of carbon-based scaffolds (B) for two weeks until the thymic stromal cell coverage of the scaffold disc was approximately 80%. To this cell-scaffold construct lymphocyte progenitor cells were added (C) and over the subsequent 21 days any non-adherent cells were counted and phenotyped by flow cytometry (D) (Poznansky et al. 2000) . thymus regeneration strategies. IL-7, cloned and expressed in conjunction with the β-chain of hepatocyte growth factor has also been shown to stimulate proliferation of thymic epithelium and consequently support T cell production ). Use of molecular therapeutic agents to harness inherent thymus regeneration potential is an attractive strategy for thymus repair and replacement and it will be of interest to follow this field of study as progress is made towards clinical therapy. . These individuals showed no evidence of graft versus host disease and generated T cells were tolerant of self, mESC and transplanted bone marrow antigens. These results highlight the potential of this technique for the rapid reestablishment of the immune system following ablation therapy. Recent studies with mouse induced pluripotent stem cells (miPSC) have used chemically defined conditions for the generation of thymic epithelial progenitor cells that have the capacity to differentiate to medullary epithelial cells (Inami et al. 2011) . Studies with human pluripotent stem cells are not yet as advanced as those involving mouse cells, however recent data with both human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) have described the differentiation of these cells to an anterior foregut endoderm phenotype (Green et al. 2011 ). This step is important in the production of human thymic progenitor and epithelial cells in vitro, as this is the germ layer from which these cells derive during in vivo organogenesis (Gordon et al. 2004) . ). An alternative study with human HSC derived T cell precursors showed that human skin derived cells were capable of directing differentiation to a T cell phenotype (Clark et al. 2005) . In this study skin derived keratinocytes and fibroblasts were seeded to a tantalum coated carbon matrix and co-cultured with lymphocyte precursors producing functionally mature T cells with a diverse receptor repertoire and evidence of selftolerance. As well as cell culture models, some studies have attempted to utilise transgenic animal models, such as swine, to direct differentiation of human bone marrow derived HSC leading to the generation human T cells which respond to human antigen presenting cells (Ogle et al. 2009 ).
Thymic Epithelial Cells from ES Cells

A B Generation of T cells in vitro
Methods which utilise the differentiation of ESC to generate T cells have also been investigated, with different factors being used to induce differentiation. The thymic peptides thymosin alpha-1 and thymopeptides have been shown to induce sequential differentiation of mESC in an embryoid body system to CD4/CD8 T cells (Peng et al. 2008) . Reaggregate thymic organ cultures have been used as a model system to study the differentiation of haematopoietic precursor cells derived from mESC co-cultured with OP9-DL1 stromal cells (de Pooter et al. 2003) . These precursor cells were isolated from early stage differentiating mESC prior to introduction to the culture system and confirmed the ability of the thymus to induce differentiation of mESC derived precursor HSC. Further studies using OP9 cells in co-culture with hESC have also shown that hESC can be differentiated to a lymphocyte lineage under the influence of delta-like-1 ligand ).
Generation of T cells for transplantation is a potential strategy for reconstitution of the immune system; it is also a potential method to induce tolerance to tissue engineered products, reducing the possibility of rejection. However this method also requires the presence of a functional thymus to continue the production of T cells which allow tolerance to the transplant, thereby highlighting the potential need to either engineer a functional thymus or find methods to reverse age related thymic atrophy (Seach et al. 2007 ).
Secondary Lymphoid Organs
SLO are fundamental constituents of the mammalian immune system comprising, for example, lymph nodes, spleen and tonsils. SLO are reservoirs for mature lymphocytes in the periphery of the body, away from sites of lymphopoiesis, and act as sites of lymphocyte activation upon antigen presentation (Cyster 1999 As with the thymus, the structure of SLO is very important for tissue function, although in these instances this is due to the need to mount an efficient immune response to foreign antigens rather than the development of T cells (Mebius and Kraal 2005) . This immune response is a complex chemokine driven process in which antigen presenting cells migrate through the SLO interacting with lymphocytes and potentially causing activation and thus an immune response (Cyster 2005) . Structurally there are differences between SLO, with the spleen consisting of two main regions, the red pulp, involved in erythrocyte filtration, and the white pulp which contains the lymphocyte population with further subdivisions based upon localisation of T and B cells and antigen presentation (Tan and Watanabe 2010). Lymph node structure is similar to the white pulp and is composed of cortical and medullary regions which contain lymphocytes and antigen presenting cells, however they lack analogous regions to the red pulp (Cyster 2005) . This also highlights a major difference between these two SLO, the spleen is presented by antigens from the blood, whereas the lymph nodes are supplied by lymphatic vessels.
Diseases of the Spleen and SLO
There are several conditions which lead to abnormal function of the spleen and SLO and potentially necessitate treatment or excision. Of the conditions which affect the spleen, splenomegaly, or the enlargement of the spleen, is the most common and can arise due to leukaemia and lymphoma. Other causes of splenomegaly include Epstein-Barr virus infection, sickle cell anaemia and malaria, leading to abnormal splenic function (Stuart and Nagel 2004) . Following diagnosis of splenomegaly individuals may require a full or partial splenectomy to remove the enlarged area.
Splenectomy may also be required in instances of trauma or rupture leading to internal bleeding, though use of this procedure is declining (Di Sabatino et al. 2011) . As well as splenectomy, individuals can be asplenic and lack a functional spleen for several other reasons including rare congenital conditions or through acquired means such as sickle-cell anaemia. Several other diseases, such as coeliac disease and rheumatoid arthritis, can lead to individuals being hyposplenic and having reduced splenic function (Di Sabatino et al. 2011) . Hyposplenia or asplenia can lead to complications with individuals being at greater risk of developing sepsis and having an increased susceptibility to infection. Additionally the risk of thrombus formation increases due to increased platelet circulation and individuals may not respond to vaccination as well due to the function of the spleen in harbouring mature T cells. There is also evidence to suggest that splenectomised patients are at greater risk of developing hyperglycemia and potentially diabetes (Ley et al. 2012 ).
Conditions which affect the lymph nodes are generally grouped together under the term lymphadenopathies due to the overall swelling of the tissue, however within this term there are distinct etiologies. The most common cause of lymphadenopathy is in response to infection and occurs due to T cell expansion within the lymph node and trafficking of T cells from the blood. Lymphadenitis is a form of lymphadenopathy which can also occur due to infection but is caused by microbiological infection within the lymph node leading to swelling. However, these conditions are common, do not require excision and are most often benign. Serious forms of lymphadenopathy where lymph nodes are abnormal in size, consistency or number are often due to primary or metastatic tumours where neoplastic proliferation leads to an increase in the size of the nodes (Ferrer 1998) . Primary tumours, lymphoma and leukaemia occur when lymphocytes or macrophages undergo neoplastic proliferation within the lymph node. Metastatic tumours occur when cancerous cells from tumours located in other organs infiltrate the lymphatic system and migrate to the lymph nodes leading to secondary tumour formation. In these instances lymphadenectomy can be required to remove the tumour, which can lead to complications such as lymphoedema or a lymphocele leading to tissue swelling around the excision site (Gould et al. 2001) .
SLO Tissue Engineering
Attempts to recreate SLO have so far been fairly limited compared to other tissues; however there have been some interesting studies which have attempted to engineer these important organs, many of which are detailed by Tan Of the tissues generated one of the first studies was the engineering of generic SLO tissue organoids (Suematsu and Watanabe 2004) . In this work thymus stromal cells were embedded into collagenous scaffolds prior to transplantation to a mouse kidney capsule. This led to the formation of structures with morphological similarities to SLO, such as areas of B and T cell organisation and follicular dendritic cell networks. It was also found that these lymphoid structures had functional similarities in the production of antibodies to introduced antigens. Subsequent studies developed artificial lymph nodes and showed that following transplantation to mice these structures were able to initiate a sustained immune response up to four weeks post-transplantation and that lymphoid cells from the nodes migrated to, and expanded in, the spleen and bone marrow (Okamoto et al. 2007 ).
Bioreactors have been designed for the culture of artificial lymph nodes in vitro, in one early study induced dendritic cells were seeded to an agarose-polyamide matrix and co-cultured with lymphocytes (Giese et al. 2006) . Following a two-week culture period these lymphocytes showed clustering on the matrix and evidence of activation in response to stimulation. Indeed it has been shown that the use of threedimensional bioreactors can maintain SLO stromal cells in culture and can partially recapitulate the structure, organisation and function of the organs in vitro demonstrating the potential for these systems in studying SLO and trying to recreate them for transplantation (Kuzin et al. 2011 ).
Some studies have attempted to develop scaffolds which support the generation of functional lymph node-like structures, such as an agarose-polyamide matrix (Giese et al. 2006 ). Other studies have utilised polyethylene glycolbased hydrogels with ordered macropores coated with extracellular matrix proteins to enhance dendritic cell attachment to, and lymphocyte migration through, the scaffold (Irvine et al. 2008 ). These scaffolds support interactions between dendritic cells and lymphocytes and can be functionalised so they contain cytokines and chemokines for sustained release during culture, giving them further utility. Further studies with macroporous scaffolds employed porous polyurethane scaffolds containing type I collagen and Matrigel to assess the importance of interstitial flow on immune cell migration and the correct development of lymph nodes in vitro (Tomei et al. 2009 ).
The work mentioned previously has examined lymph node generation or a generic SLO, however other studies have attempted to specifically engineer a spleen-like organ in vitro, prior to implantation and bacterial challenge (Grikscheit et al. 2008) . In this work tissue fragments of juvenile rat spleen were seeded to tubular scaffolds of nonwoven polyglycolic acid sheets, sealed with poly-L-lactic acid (in chloroform solvent) before implantation to splenectomised rats. Following implantation pneumococcal sepsis was induced and rat survival was shown to be significantly greater in rats with tissue engineered spleen compared to spleen slices and untreated splenectomised rats. This work highlights the potential of using tissue engineered SLO compared to traditional methods and demonstrates the need for such solutions, especially in younger immunocompromised patients.
Many of the methods to reproduce SLO in vitro which have been detailed rely on fibroblastic cell lines or the recapitulation of SLO cells into a SLOlike structure with the assistance of scaffolds and bioreactors, however, alternative cell sources may be required for this work to progress clinically. Presently there are few protocols for the differentiation of stem cells to a SLO stromal cell phenotype. Recent work has identified adipocyte precursor cells present within the embryonic fat pad and lymph node stroma with the capacity to differentiate to lymph node stromal organiser cells, linking lymphoid development with adipose tissue (Bénézech et al. 2012 ). This offers the attractive possibility of utilising a patient's own adipose precursor cells to produce lymphoid stromal cells in vitro prior to implantation into the patient ).
Conclusion
Recapitulation of functional lymphoid tissue is a challenging area within tissue engineering due to the complexity of the organs and the requirement for specific architectures. However, should these difficulties be overcome, then regeneration of lymphoid tissue could lead to great gains in several therapeutic areas (Cupedo et al. 2012) . For individuals who have suffered loss of lymphoid organs through disease or surgical intervention, the possibility of organ replacement may lead to the reestablishment of immune function and likewise for those who have reduced circulating lymphocytes following disease. These applications are not the limit for engineered lymphoid tissue, it may be possible to utilise lymphoid tissue engineering in concert with other surgical interventions to reduce the possibility of immune rejection of transplanted allogeneic tissue or engineered tissue. Additionally there is great interest in using artificial lymphoid organs as a treatment for some forms of cancer. As such engineering of lymphoid tissues is an important area of research for a multitude of conditions and one which is beginning to increase in recognition.
